 |
|
Drug could improve pregnancy outcomes in wider range of women with insulin resistance
September 07, 2007Women who are obese, have type 2 diabetes or a family history of type 2 diabetes could one day have more successful pregnancies because of a study at Washington University School of Medicine in St. Louis.
This study, performed in mice, suggests that Metformin, the most commonly prescribed anti-diabetes drug, could potentially improve pregnancy outcomes in women with insulin resistance.
"We found that embryos of insulin-resistant mice also have some degree of insulin resistance, and if we correct the insulin resistance in the embryo with this drug, we improve the quality of the embryo," says Kelle Moley, M.D., lead author and professor of obstetrics and gynecology.
The finding, published online in Diabetes, suggests that Metformin could benefit women with type 2 diabetes or polycystic ovary syndrome (PCOS). About 8 percent of women trying to conceive have insulin resistance, Moley says, and even more are suspected to be borderline. In some cases, a family history of type 2 diabetes or being overweight may be the only indication that the patient may be prone to insulin resistance.
Metformin is often given to women with PCOS, an endocrine disorder that affects insulin and results in higher rates of miscarriage. These women often share the same pregnancy complications as women with type 2 diabetes and obesity.
Recent studies have shown that metformin not only aids conception in women with PCOS but also reduces the high miscarriage rates; however, how the drug does this has been unclear.
Using early-stage mouse embryos, Moley and her colleagues showed for the first time that metformin improves insulin action in insulin-resistant embryos. That allowed the embryos to absorb glucose, an important energy source, and prevented the death of cells in the embryos. As a result, the embryos were more likely to successfully implant in the uterus and to continue growing.
Moley's group also identified the molecular mechanism that accounts for metformin's positive effects. They found the drug triggers an important sensor of the energy level of cells, which sets off a chain of reactions that help insulin do its job. Previously it was not known that this sensor molecule was active in early embryos.
Moley hypothesizes that in insulin-resistant women, high levels of insulin and related factors cause their embryos to compensate by shutting down insulin signaling mechanisms. That impairs the early embryo's ability to take in glucose at a critical stage of development and can lead to pregnancy failure.
"We found that Metformin improves glucose uptake and improves the survival of the early embryo as a result," Moley says. "Mouse embryos in a high-insulin environment that were not exposed to Metformin did not survive."
Most miscarriages are due to chromosomal abnormalities. But Moley says this study provides new scientific evidence that miscarriages related to insulin resistance possibly could be avoided through the use of metformin.
"This will help physicians know better how to treat these women and reassure them that they're being correctly treated for their medical problems and that their babies will benefit from that treatment," she says.
Washington University School of Medicine
The finding, published online in Diabetes, suggests that Metformin could benefit women with type 2 diabetes or polycystic ovary syndrome (PCOS). About 8 percent of women trying to conceive have insulin resistance, Moley says, and even more are suspected to be borderline. In some cases, a family history of type 2 diabetes or being overweight may be the only indication that the patient may be prone to insulin resistance.
Metformin is often given to women with PCOS, an endocrine disorder that affects insulin and results in higher rates of miscarriage. These women often share the same pregnancy complications as women with type 2 diabetes and obesity.
Recent studies have shown that metformin not only aids conception in women with PCOS but also reduces the high miscarriage rates; however, how the drug does this has been unclear.
Using early-stage mouse embryos, Moley and her colleagues showed for the first time that metformin improves insulin action in insulin-resistant embryos. That allowed the embryos to absorb glucose, an important energy source, and prevented the death of cells in the embryos. As a result, the embryos were more likely to successfully implant in the uterus and to continue growing.
Moley's group also identified the molecular mechanism that accounts for metformin's positive effects. They found the drug triggers an important sensor of the energy level of cells, which sets off a chain of reactions that help insulin do its job. Previously it was not known that this sensor molecule was active in early embryos.
Moley hypothesizes that in insulin-resistant women, high levels of insulin and related factors cause their embryos to compensate by shutting down insulin signaling mechanisms. That impairs the early embryo's ability to take in glucose at a critical stage of development and can lead to pregnancy failure.
"We found that Metformin improves glucose uptake and improves the survival of the early embryo as a result," Moley says. "Mouse embryos in a high-insulin environment that were not exposed to Metformin did not survive."
Most miscarriages are due to chromosomal abnormalities. But Moley says this study provides new scientific evidence that miscarriages related to insulin resistance possibly could be avoided through the use of metformin.
"This will help physicians know better how to treat these women and reassure them that they're being correctly treated for their medical problems and that their babies will benefit from that treatment," she says.
Washington University School of Medicine
Insulin Current Events and Insulin News RSSPure insulin-producing cells produced in mouse
Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs).
Researcher tricks immune system in diabetic mice
The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it.
Systems biology brings hope of speeding up drug development
Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade.
Garlic chemical tablet treats diabetes I and II
A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says.
New insight into the controls on a go-to enzyme
Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains.
Vitamin C lowers levels of heart disease biomarker, finds study, adds to debate of health benefits
A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes.
New hybrid plants could prompt more prodigious pepper production in Southwest
By themselves or as an ingredient in a variety of foods, including salsa, America's top-selling condiment, peppers have found a warm spot in the hearts and stomachs of U.S. consumers.
Drug mimics low-cal diet to ward off weight gain, boost running endurance
A drug designed to specifically hit a protein linked to the life-extending benefits of a meager diet can essentially trick the body into believing food is scarce even when it isn't, suggests a new report in the November Cell Metabolism.
Apelin hormone injections powerfully lower blood sugar
By injecting a hormone produced by fat and other tissues into mice, researchers report in the November Cell Metabolism that they significantly lowered blood sugar levels in normal and obese mice.
An Anti-Frailty Pill for Seniors?
Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty.
More Insulin Current Events and Insulin News Articles
 | The Insulin-Resistance Diet--Revised and Updated: How to Turn Off Your Body's Fat-Making Machine by Cheryle Hart, Mary Kay Grossman Conquer insulin resistance. Reduce cravings. Eat your favorite foods. And lose weight!. If you have tried every diet and are still struggling with your weight, the real culprit may be insulin resistance. When you have more glucose than your body needs, your body responds by producing more insulin to stabilize your blood sugar level and store the excess glucose as fat. In The Insulin-Resistance... |
 | Pumping Insulin: Everything You Need For Success On A Smart Insulin Pump by John Walsh, Ruth Roberts |
 | The Discovery of Insulin: Twenty-fifth Anniversary Edition by Michael Bliss When insulin was discovered in the early 1920s, even jaded professionals marveled at how it brought starved, sometimes comatose diabetics back to life. In this now-classic study, Michael Bliss unearths a wealth of material, ranging from scientists’ unpublished memoirs to the confidential appraisals of insulin by members of the Nobel Committee. He also resolves a longstanding controversy dating... |
 | Syndrome X: The Complete Nutritional Program to Prevent and Reverse Insulin Resistance by Jack Challem, Burton Berkson, Melissa Diane Smith You can feel great again! "Syndrome X proactively lays out a nutritious, tasty, and simple diet plan to get us back to the basics of healthy nutrition."-Lendon H. Smith, M.D., New York Times bestselling author of Feed Your Body Right "Syndrome X is the best new book to help you understand the facts about nutrition, health, and aging. . . . It is full of new information and insights... |
 | Using Insulin, Everything You Need for Success With Insulin by John Walsh, Ruth Roberts, Timothy Bailey, Chandra B. Varma |
 | Why Fat Sticks: An Introduction To Insulin Resistance by Guin Van Niekerk DO YOU FIND IT IMPOSSIBLE TO LOSE WEIGHT? HAVE YOU TRIED EVERY KNOWN DIET WITH NO SUCCESS? IS YOUR HEALTH SUFFERING? YOU COULD HAVE INSULIN RESISTANCE! Insulin Resistance is COMMON - it may affect up to one in four people. If you suffer from tiredness, irritability and constant cravings for sweet foods, you could have... |
 | Pumping Insulin: Everything You Need for Success With an Insulin Pump by John Walsh, Ruth Roberts |
 | The Glycemic-Load Diet Cookbook: 150 Recipes to Help You Lose Weight and Reverse Insulin Resistance by Rob Thompson, Dana Carpender Now you can eat up, slim down, and control insulin--with 150 easy recipes that are scientifically designed and sinfully good. . Imagine being able to lose weight while enjoying satisfying amounts of delicious food. Now, thanks to Dr. Rob Thompson's revolutionary eating plan based on the breakthrough science of the glycemic load, you can prepare fabulously filling meals that actually speed up... |
 | Using Insulin Pumps in Diabetes: A Guide for Nurses and Other Health Professionals by Jill Rodgers Insulin pump therapy is now a well-established option for treating diabetes. This method of insulin delivery offers the opportunity for people with diabetes to manage their diabetes confidently and competently to achieve good glycaemic control and a better quality of life. Using Insulin Pumps in Diabetes covers all aspects of insulin pump therapy in a clear and informative style, and is an... |
 | Running Shoes Are Cheaper Than Insulin: Marathon Adventures on All Seven Continents by Anthony Reed, Tony Reed This book is a collection of 25 years of stories, 295 photos, and travel logs about running marathons around the world. Fewer than 225 people have run marathons on all seven continents. To put this in perspective, over 500 people reached the summit of Mt. Everest in 2007 alone. The author joined this elite seven continents marathon group in 2007. Subsequently, his professional and athletic... |
| © 2008 BrightSurf.com |